| Trial Identifier: | 1045-008 |
| Sponsor: | Merck |
| Start Date: | May 2026 |
| Primary Completion Date: | July 2030 |
| Study Completion Date: | April 2031 |
| Condition: | Non-Hodgkin's Lymphoma |
For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.
| Language | Description |
| Protocol Plain Language Summary |
| Country | Location |
|---|---|
| Argentina, Santa Fe | Rosario, Santa Fe, Argentina, 2001 |
| China, Beijing | Beijing, China, 100142 |
| Israel, N/A | Jerusalem, N/A, Israel, 9103102 |
| Israel, N/A | Jerusalem, N/A, Israel, 9112001 |
| Israel, N/A | Ramat Gan, N/A, Israel, 5265601 |
| Israel, N/A | Tel Aviv, N/A, Israel, 6423906 |
| Italy, Piemonte | Candiolo, Piemonte, Italy, 10060 |
| Poland, Mazowieckie | Warszawa, Mazowieckie, Poland, 02-781 |
| Poland, Slaskie | Katowice, Slaskie, Poland, 40-519 |
| Spain, Barcelona | Barcelona, Spain, 08035 |
| Spain, Madrid | Madrid, Spain, 28007 |
| Spain, Madrid | Madrid, Spain, 28041 |
| United Kingdom, Manchester | Manchester, United Kingdom, M20 4BX |
Powered by
Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered office is 3 More London Riverside, London SE1 2AQ.
Copyright © 2026 Pharma Intelligence UK Limited (Citeline), a Norstella company